These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15834407)

  • 1. Suppression of HIV-1 infection by a small molecule inhibitor of the ATM kinase.
    Lau A; Swinbank KM; Ahmed PS; Taylor DL; Jackson SP; Smith GC; O'Connor MJ
    Nat Cell Biol; 2005 May; 7(5):493-500. PubMed ID: 15834407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATM: HIV-1's Achilles heel?
    Daniel R; Pomerantz RJ
    Nat Cell Biol; 2005 May; 7(5):452-3. PubMed ID: 15867928
    [No Abstract]   [Full Text] [Related]  

  • 3. Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response.
    Golding SE; Rosenberg E; Neill S; Dent P; Povirk LF; Valerie K
    Cancer Res; 2007 Feb; 67(3):1046-53. PubMed ID: 17283137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HIV-1 replication by caffeine and caffeine-related methylxanthines.
    Nunnari G; Argyris E; Fang J; Mehlman KE; Pomerantz RJ; Daniel R
    Virology; 2005 May; 335(2):177-84. PubMed ID: 15840517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of unrepaired DNA double strand breaks caused by inhibition of ATM does not lead to radio-sensitisation in the absence of NF-κB activation.
    Veuger SJ; Durkacz BW
    DNA Repair (Amst); 2011 Feb; 10(2):235-44. PubMed ID: 21144805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ataxia telangiectasia mutated and p21CIP1 modulate cell survival of drug-induced senescent tumor cells: implications for chemotherapy.
    Crescenzi E; Palumbo G; de Boer J; Brady HJ
    Clin Cancer Res; 2008 Mar; 14(6):1877-87. PubMed ID: 18347191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of heterochromatin on DSB repair.
    Goodarzi AA; Noon AT; Jeggo PA
    Biochem Soc Trans; 2009 Jun; 37(Pt 3):569-76. PubMed ID: 19442252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium salicylate acts through direct inhibition of phosphoinositide 3-kinase-like kinases to modulate topoisomerase-mediated DNA damage responses.
    Fan JR; Huang TH; Wen CY; Shen TL; Li TK
    Eur J Pharmacol; 2010 Jul; 638(1-3):13-20. PubMed ID: 20406630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of transforming growth factor-beta1 signaling attenuates ataxia telangiectasia mutated activity in response to genotoxic stress.
    Kirshner J; Jobling MF; Pajares MJ; Ravani SA; Glick AB; Lavin MJ; Koslov S; Shiloh Y; Barcellos-Hoff MH
    Cancer Res; 2006 Nov; 66(22):10861-9. PubMed ID: 17090522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase.
    Hollick JJ; Rigoreau LJ; Cano-Soumillac C; Cockcroft X; Curtin NJ; Frigerio M; Golding BT; Guiard S; Hardcastle IR; Hickson I; Hummersone MG; Menear KA; Martin NM; Matthews I; Newell DR; Ord R; Richardson CJ; Smith GC; Griffin RJ
    J Med Chem; 2007 Apr; 50(8):1958-72. PubMed ID: 17371003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ataxia telangiectasia mutated and checkpoint kinase 2 regulate BRCA1 to promote the fidelity of DNA end-joining.
    Wang HC; Chou WC; Shieh SY; Shen CY
    Cancer Res; 2006 Feb; 66(3):1391-400. PubMed ID: 16452194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATM is involved in cell-cycle control through the regulation of retinoblastoma protein phosphorylation.
    Pizarro JG; Folch J; de la Torre AV; Junyent F; Verdaguer E; Jordan J; Pallas M; Camins A
    J Cell Biochem; 2010 May; 110(1):210-8. PubMed ID: 20213763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA-PK, ATM and MDR proteins inhibitors in overcoming fludarabine resistance in CLL cells.
    Svirnovski AI; Serhiyenka TF; Kustanovich AM; Khlebko PV; Fedosenko VV; Taras IB; Bakun AV
    Exp Oncol; 2010 Dec; 32(4):258-62. PubMed ID: 21270755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA repair in HIV-1 infection: a case for inhibitors of cellular co-factors?
    Daniel R
    Curr HIV Res; 2006 Oct; 4(4):411-21. PubMed ID: 17073616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV type 1 integrase inhibitors: from basic research to clinical implications.
    Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
    AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ATM-dependent DNA damage signaling pathway.
    Kitagawa R; Kastan MB
    Cold Spring Harb Symp Quant Biol; 2005; 70():99-109. PubMed ID: 16869743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronicles in drug discovery.
    Khurdayan V; Bozzo J; Sorbera L
    Drug News Perspect; 2005 Jun; 18(5):332-6. PubMed ID: 16193105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion.
    Golding SE; Rosenberg E; Valerie N; Hussaini I; Frigerio M; Cockcroft XF; Chong WY; Hummersone M; Rigoreau L; Menear KA; O'Connor MJ; Povirk LF; van Meter T; Valerie K
    Mol Cancer Ther; 2009 Oct; 8(10):2894-902. PubMed ID: 19808981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 Vpr induces ATM-dependent cellular signal with enhanced homologous recombination.
    Nakai-Murakami C; Shimura M; Kinomoto M; Takizawa Y; Tokunaga K; Taguchi T; Hoshino S; Miyagawa K; Sata T; Kurumizaka H; Yuo A; Ishizaka Y
    Oncogene; 2007 Jan; 26(4):477-86. PubMed ID: 16983346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asperlin induces G₂/M arrest through ROS generation and ATM pathway in human cervical carcinoma cells.
    He L; Nan MH; Oh HC; Kim YH; Jang JH; Erikson RL; Ahn JS; Kim BY
    Biochem Biophys Res Commun; 2011 Jun; 409(3):489-93. PubMed ID: 21600879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.